India’s Biotech Sector Expands with Focus on Biologics and Genomics

India's bioeconomy reached a valuation of USD 195.3 billion in 2025, driven by growth in biologics, biosimilars, genomics, and cell therapies.

Startups account for about 12,000 entities in the biotech space, with approximately 30 percent operating within the healthcare sector.

The 2024 BioE3 Policy identifies precision biotherapeutics, mRNA therapies, and Bio-AI-enabled biomanufacturing as priority growth areas.